Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

1.

The search of potential inhibitors of the AcrAB-TolC system of multidrug-resistant Escherichia coli: an in silico approach.

Abdel-Halim H, Al Dajani A, Abdelhalim A, Abdelmalek S.

Appl Microbiol Biotechnol. 2019 Aug;103(15):6309-6318. doi: 10.1007/s00253-019-09954-1. Epub 2019 Jun 17.

PMID:
31209525
2.

Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma.

Diab O, Mcentire D, Kassim T, Nayfeh A, Dajani AR, Kerfeld M, Campbell J, Alsuwaidan A, Hazeem MA, Gbadamosi-Akindele M.

Case Rep Oncol Med. 2019 Jan 8;2019:7928752. doi: 10.1155/2019/7928752. eCollection 2019.

3.

Investigational drugs for the treatment of acute myocardial infarction: focus on antiplatelet and anticoagulant agents.

Yandrapalli S, Andries G, Gupta S, Dajani AR, Aronow WS.

Expert Opin Investig Drugs. 2019 Mar;28(3):223-234. doi: 10.1080/13543784.2019.1559814. Epub 2018 Dec 22. Review.

PMID:
30580647
4.

Genome-wide association study identifies novel type II diabetes risk loci in Jordan subpopulations.

Dajani R, Li J, Wei Z, March ME, Xia Q, Khader Y, Hakooz N, Fatahallah R, El-Khateeb M, Arafat A, Saleh T, Dajani AR, Al-Abbadi Z, Abdul Qader M, Shiyab AH, Bateiha A, Ajlouni K, Hakonarson H.

PeerJ. 2017 Aug 17;5:e3618. doi: 10.7717/peerj.3618. eCollection 2017.

5.

Standard triple therapy versus sequential therapy for eradication of Helicobacter pylori in treatment naïve and retreat patients.

Abuhammour A, Dajani A, Nounou M, Zakaria M.

Arab J Gastroenterol. 2016 Sep;17(3):131-136. doi: 10.1016/j.ajg.2016.07.001. Epub 2016 Sep 21.

PMID:
27665525
6.

Epidemiological evaluation of acute gastroenteritis and therapeutic approaches in Middle East Countries.

Ayoub D, Lopetuso LR, Chamseddine F, Dajani A, Lahiri K, Mahmoud H, Miqdady MS, Zirizzotti G, Sultan MA, Franceschi F, Gasbarrini A.

Eur Rev Med Pharmacol Sci. 2016 Sep;20(18):3891-3901.

7.

New combined parameter of liver and splenic stiffness as determined by elastography in healthy volunteers.

Kassym L, Nounou MA, Zhumadilova Z, Dajani AI, Barkibayeva N, Myssayev A, Rakhypbekov T, Abuhammour AM.

Saudi J Gastroenterol. 2016 Jul-Aug;22(4):324-30. doi: 10.4103/1319-3767.187607.

8.

Treatment of nonalcoholic fatty liver disease: Where do we stand? an overview.

Dajani A, AbuHammour A.

Saudi J Gastroenterol. 2016 Mar-Apr;22(2):91-105. doi: 10.4103/1319-3767.178527. Review.

9.

Essential phospholipids as a supportive adjunct in the management of patients with NAFLD.

Dajani AI, Abu Hammour AM, Zakaria MA, Al Jaberi MR, Nounou MA, Semrin AI.

Arab J Gastroenterol. 2015 Sep-Dec;16(3-4):99-104. doi: 10.1016/j.ajg.2015.09.001. Epub 2015 Nov 14.

PMID:
26589371
10.

Do probiotics improve eradication response to Helicobacter pylori on standard triple or sequential therapy?

Dajani AI, Abu Hammour AM, Yang DH, Chung PC, Nounou MA, Yuan KY, Zakaria MA, Schi HS.

Saudi J Gastroenterol. 2013 May-Jun;19(3):113-20. doi: 10.4103/1319-3767.111953.

11.

Prevalence of coagulation factor II G20210A and factor V G1691A Leiden polymorphisms in Chechans, a genetically isolated population in Jordan.

Dajani R, Fatahallah R, Dajani A, Al-Shboul M, Khader Y.

Mol Biol Rep. 2012 Sep;39(9):9133-8. doi: 10.1007/s11033-012-1785-7. Epub 2012 Jun 29.

PMID:
22744422
12.

Can Doppler sonography be used to diagnose neonatal cerebral infarction caused by portal vein thrombosis.

Dajani AA, Al-Ghamdi MA, Al-Baradie RS, Al-Saif SA.

Neurosciences (Riyadh). 2009 Jul;14(3):280-3.

PMID:
21048631
13.

Importance of Helicobacter pylori eradcation for maintenance of remission of drug associated peptic ulcer disease.

Dajani A, Dham R, El-Sahhar M, Subeih S, El Sheikh S, Mansour A, El-Ebeidi G, Mohammed S, El Horaibi M, Al Gawli A, Al-Anzi A, Gautham S, Ahmed O, Hammour A, Nounou M, Al-Mardini H.

Saudi J Gastroenterol. 2006 Jan-Mar;12(1):16-20.

14.

Pregnancy anxieties and natural recognition in baby-switching.

DiPasquale Davis J, Moran MK, Horger EO 3rd, Dajani AN.

Br J Nurs. 2001 Jun 14-27;10(11):718-26.

PMID:
12048488
15.

Unique features of infective endocarditis in childhood.

Ferrieri P, Gewitz MH, Gerber MA, Newburger JW, Dajani AS, Shulman ST, Wilson W, Bolger AF, Bayer A, Levison ME, Pallasch TJ, Gage TW, Taubert KA.

Pediatrics. 2002 May;109(5):931-43. No abstract available.

PMID:
11986458
16.

Unique features of infective endocarditis in childhood.

Ferrieri P, Gewitz MH, Gerber MA, Newburger JW, Dajani AS, Shulman ST, Wilson W, Bolger AF, Bayer A, Levison ME, Pallasch TJ, Gage TW, Taubert KA; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the American Heart Association Council on Cardiovascular Disease in the Young.

Circulation. 2002 Apr 30;105(17):2115-26. No abstract available.

PMID:
11980694
17.

Beta-lactam resistance: clinical implications for pediatric patients.

Dajani AS.

J Int Med Res. 2002;30 Suppl 1:2A-9A. Review.

PMID:
11921492
18.

Use of ampicillin/sulbactam and sultamicillin in pediatric infections: a re-evaluation.

Dajani A.

J Int Med Res. 2001 Jul-Aug;29(4):257-69. Review.

PMID:
11675898
19.

Optimisation of the prevention and treatment of bacterial endocarditis.

Taubert KA, Dajani AS.

Drugs Aging. 2001;18(6):415-24. Review.

PMID:
11419916
20.

Moraxella catarrhalis bacteremia: a 10-year experience.

Abuhammour WM, Abdel-Haq NM, Asmar BI, Dajani AS.

South Med J. 1999 Nov;92(11):1071-4.

PMID:
10586832
21.

One-week triple regime therapy consisting of pantoprazole, amoxicillin and clarithromycin for cure of Helicobacter pylori-associated upper gastrointestinal diseases.

Dajani AI, Awad S, Ukabam S, Nounou MA, Abdul Rasheed Z, Gautam S, Abdul Aal G, Nayal S.

Digestion. 1999;60(3):298-304.

PMID:
10343146
22.
23.

Prevalence of penicillin-resistant viridans streptococci in the oral flora of Japanese children at risk for infective endocarditis.

Nishi J, Yoshinaga M, Nomura Y, Dajani AS, Taubert KA, Ferrieri PL.

Circulation. 1999 Mar 9;99(9):1274-5. No abstract available.

PMID:
10069927
24.

Are the Duke criteria superior to the Beth Israel criteria for the diagnosis of infective endocarditis in children?

Stockheim JA, Chadwick EG, Kessler S, Amer M, Abdel-Haq N, Dajani AS, Shulman ST.

Clin Infect Dis. 1998 Dec;27(6):1451-6.

PMID:
9868659
25.

Diagnosis and management of infective endocarditis and its complications.

Bayer AS, Bolger AF, Taubert KA, Wilson W, Steckelberg J, Karchmer AW, Levison M, Chambers HF, Dajani AS, Gewitz MH, Newburger JW, Gerber MA, Shulman ST, Pallasch TJ, Gage TW, Ferrieri P.

Circulation. 1998 Dec 22-29;98(25):2936-48. Review. No abstract available.

PMID:
9860802
26.

Prevention of bacterial endocarditis: highlights of the latest recommendations by the American Heart Association.

Dajani AS.

Pediatr Infect Dis J. 1998 Sep;17(9):824-5. No abstract available.

PMID:
9779771
27.

Current therapy of group A streptococcal pharyngitis.

Dajani AS.

Pediatr Ann. 1998 May;27(5):277-80. No abstract available.

PMID:
9622810
28.

Comparison of ampicillin/sulbactam plus aminoglycoside vs. ampicillin plus clindamycin plus aminoglycoside in the treatment of intraabdominal infections in children. The Multicenter Group.

Collins MD, Dajani AS, Kim KS, King DR, Kaplan SL, Azimi PH, Kolokathis A, Swanson R.

Pediatr Infect Dis J. 1998 Mar;17(3 Suppl):S15-8; discussion S20-1. No abstract available.

PMID:
9519910
29.

Preventing bacterial endocarditis: American Heart Association guidelines.

Taubert KA, Dajani AS.

Am Fam Physician. 1998 Feb 1;57(3):457-68.

30.

Prevention of bacterial endocarditis: recommendations by the American Heart Association.

Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, Gewitz MH, Shulman ST, Nouri S, Newburger JW, Hutto C, Pallasch TJ, Gage TW, Levison ME, Peter G, Zuccaro G Jr.

Clin Infect Dis. 1997 Dec;25(6):1448-58.

PMID:
9431393
31.

Prevention of bacterial endocarditis: recommendations by the American Heart Association.

Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, Gewitz MH, Shulman ST, Nouri S, Newburger JW, Hutto C, Pallasch TJ, Gage TW, Levison ME, Peter G, Zuccaro G Jr.

J Am Dent Assoc. 1997 Aug;128(8):1142-51.

PMID:
9260427
32.

Prevention of bacterial endocarditis. Recommendations by the American Heart Association.

Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, Gewitz MH, Shulman ST, Nouri S, Newburger JW, Hutto C, Pallasch TJ, Gage TW, Levison ME, Peter G, Zuccaro G Jr.

Circulation. 1997 Jul 1;96(1):358-66. Review.

PMID:
9236458
33.

Prevention of bacterial endocarditis. Recommendations by the American Heart Association.

Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, Gewitz MH, Shulman ST, Nouri S, Newburger JW, Hutto C, Pallasch TJ, Gage TW, Levison ME, Peter G, Zuccaro G Jr.

JAMA. 1997 Jun 11;277(22):1794-801. Review.

PMID:
9178793
34.

Use of electrophoretic karyotyping in the evaluation of Candida infections in a neonatal intensive-care unit.

Vazquez JA, Boikov D, Boikov SG, Dajani AS.

Infect Control Hosp Epidemiol. 1997 Jan;18(1):32-7.

PMID:
9013244
35.

Absence of bacteremia after gastrointestinal procedures in children.

el-Baba M, Tolia V, Lin CH, Dajani A.

Gastrointest Endosc. 1996 Oct;44(4):378-81.

PMID:
8905353
36.

Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States.

Chen RT, Hausinger S, Dajani AS, Hanfling M, Baughman AL, Pallansch MA, Patriarca PA.

JAMA. 1996 Jun 5;275(21):1639-45.

PMID:
8637136
37.

Adherence to physicians' instructions as a factor in managing streptococcal pharyngitis.

Dajani AS.

Pediatrics. 1996 Jun;97(6 Pt 2):976-80. Review.

PMID:
8637785
38.

Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections.

Jacobs RF, Kaplan SL, Schutze GE, Dajani AS, Leggiadro RJ, Rim CS, Puri SK.

Antimicrob Agents Chemother. 1996 Apr;40(4):895-8.

39.

Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association.

Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye D, Bisno AL, Ferrieri P, Shulman ST, Durack DT.

JAMA. 1995 Dec 6;274(21):1706-13.

PMID:
7474277
41.

Cefotaxime use in pediatric infections.

Dajani AS.

Diagn Microbiol Infect Dis. 1995 May-Jun;22(1-2):105-10. Review.

PMID:
7587022
42.

Pharyngitis/tonsillitis: European and United States experience with cefpodoxime proxetil.

Dajani AS.

Pediatr Infect Dis J. 1995 Apr;14(4 Suppl):S7-11. Review.

PMID:
7792129
43.

Comparison of cefpodoxime proxetil and cefixime in the treatment of acute otitis media in infants and children. Otitis Study Group.

Asmar BI, Dajani AS, Del Beccaro MA, Mendelman PM.

Pediatrics. 1994 Dec;94(6 Pt 1):847-52.

PMID:
7971000
44.

Value of throat cultures in adolescents taking daily antibiotics for acne.

Dajani AS.

Pediatr Infect Dis J. 1994 Sep;13(9):842-3. No abstract available.

PMID:
7808867
45.

Increasing Enterobacter bacteremia in pediatric patients.

Andresen J, Asmar BI, Dajani AS.

Pediatr Infect Dis J. 1994 Sep;13(9):787-92.

PMID:
7808847
46.

Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Dajani AS, Taubert KA, Takahashi M, Bierman FZ, Freed MD, Ferrieri P, Gerber M, Shulman ST, Karchmer AW, Wilson W, et al.

Circulation. 1994 Feb;89(2):916-22.

PMID:
8313588
47.

Oral amoxicillin as prophylaxis for endocarditis: what is the optimal dose?

Dajani AS, Bawdon RE, Berry MC.

Clin Infect Dis. 1994 Feb;18(2):157-60.

PMID:
8161620
48.

Report of the task force on children and youth. American Heart Association.

Moller JH, Allen HD, Clark EB, Dajani AS, Golden A, Hayman LL, Lauer RM, Marmer EL, McAnulty JH, Oparil S, et al.

Circulation. 1993 Nov;88(5 Pt 1):2479-86. No abstract available.

PMID:
8222143
49.

Diagnosis and therapy of Kawasaki disease in children.

Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, Takahashi M, Bierman FZ, Karchmer AW, Wilson W, et al.

Circulation. 1993 May;87(5):1776-80. Review. No abstract available.

PMID:
8491037
50.

Cefpodoxime proxetil vs. penicillin V in pediatric streptococcal pharyngitis/tonsillitis.

Dajani AS, Kessler SL, Mendelson R, Uden DL, Todd WM.

Pediatr Infect Dis J. 1993 Apr;12(4):275-9.

PMID:
8483620

Supplemental Content

Loading ...
Support Center